Lee Pharmaceuticals, Inc.

Q: Jun 30 2005

Q: Mar 31 2005

Q: Dec 31 2004

FY: Sep 30 2004

Q: Jun 30 2004

Q: Mar 31 2004

Q: Dec 31 2003

FY: Sep 30 2003

Q: Jun 30 2003

Q: Mar 31 2003

Q: Dec 31 2002

FY: Sep 30 2002

Q: Jun 30 2002

Q: Mar 31 2002

Q: Dec 31 2001

FY: Sep 30 2001

Q: Jun 30 2001

Q: Mar 31 2001

Q: Dec 31 2000

FY: Sep 30 2000

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

2.01,9.01

2.02,9.01

2.02,9.01

12

12

12

12

4,7

4,7

Current report pursuant to Section 13 or 15(d)

4

Certification of termination of registration of a class of securities (Section 12(b))

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Lee Henry L

Lee Ronald G

Annual Reports and Special Financial Reports

Exit Report Under Regulation A

1,4,7,9.1

1,4,7,9.1

No description available

No description available

No description available

Correspondence with the SEC

Regulation A Offering Statement (amendment)

Letter from the SEC

Regulation A Offering Statement (amendment)

Letter from the SEC

Regulation A Offering Statement (amendment)

Letter from the SEC

Regulation A Offering Statement

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC